Bristol-Myers Squibb Key Facts

The global business at a glance...

Chief Executive Officer (CEO):
Lamberto Andreotti
Headquarters:
New York City
Website address:
www.bms.com
Stock exchange listing:
BMY (New York Stock Exchange)
Number of employees:
27,000
Net sales:
$17.6 billion in 2012
Research and development:
$3.9 billion in 2012
Key business:
Biopharmaceuticals

The Irish business at a glance...


Swords Office:


Cruiserath Office:    


Leopardstown  Office:      

Watery Lane, Swords, Co. Dublin

Cruiserath Road, Cruiserath, Mulhuddart, Co. Dublin

South County Business Park, Leopardstown, Dublin 18
Number of employees:
>550
Key Products:
SUSTIVA® (efavirenz)
ATRIPLA® (Tenofovir disoproxil fumarate,
Efavirenz
, emtricitabine)
BYETTA® (Exenatide)
BYDUREON® (Exenatide)
BARACLUDE® (entecavir)
ELIQUIS® (apixaban)
ONGLYZA® (saxagliptin)
SUSTIVA® (efavirenz)
KOMBOGLYXE® (saxagliptin & metformin)
REYATAZ® (atazanavir sulfate)
SPRYCEL® (dasatinib)
YERVOY™ (ipilimumab)